Correction: SPAG6 hypermethylation silences a novel tumor suppressor and inhibits renal cell carcinoma progression via PI3K/AKT/mTOR pathway

Key Points

• To correct previous findings about the role of spag6 hypermethylation in renal cell carcinoma.
• Correction of DOI article
• Review of previous analyses on spag6
• Validation of findings related to the PI3K/AKT/mTOR pathway
• Spag6 hypermethylation suppresses tumor activity
• Hypomethylation could be a potential treatment target
• Inhibition of the PI3K/AKT/mTOR pathway is linked to spag6 silencing